Learn all about Atropine - its mechanism of action, indications, contraindications, side effects, nursing implications, and patient education.

Introduction

Atropine is a life-saving anticholinergic medication used to treat bradycardia, poisoning cases, and pre-operative conditions. As a competitive muscarinic antagonist, it blocks parasympathetic nervous system activity. This comprehensive guide covers everything about Atropine, including its mechanism of action, indications, contraindications, side effects, nursing responsibilities, and patient education tips.


Feature Description
Generic Name Atropine Sulfate
Trade Names Atropen, Sal-Tropine, Isopto Atropine
Class/Action Anticholinergic / Muscarinic antagonist
Blocks parasympathetic activity → ↑HR, ↓secretions
Route/Dosage IV/IM: 0.5-1mg (bradycardia)
Ophthalmic: 1% solution (eye exams)
Poisoning: 2-6mg (organophosphates)
High Alert NO
Indications • Symptomatic bradycardia
• Organophosphate poisoning
• Pre-operative medication
• Ophthalmic examinations
Mechanism of Action • Competitively blocks muscarinic acetylcholine receptors
• Inhibits parasympathetic nervous system
• Results in: ↑Heart rate, ↓secretions, pupil dilation
Contraindications • Narrow-angle glaucoma
• Tachycardia
• GI/GU obstruction
• Myasthenia gravis
Adverse Reactions • Dry mouth, blurred vision
• Tachycardia, palpitations
• Urinary retention
• Confusion, delirium (elderly)
Nursing Implications • Monitor ECG continuously (for arrhythmias)
• Assess for urinary retention
• Watch for anticholinergic toxicity
• Use caution in hot environments (↓sweating)
Patient Education • Avoid driving if blurred vision occurs
• Report rapid heartbeat or confusion
• Increase fluid intake (prevent dry mouth)
• Use sunglasses if photophobia occurs
Notes for Nurses Bradycardia: Minimum dose 0.5mg IV
Poisoning: May require very high doses
Elderly: More sensitive to CNS effects
Reversal: Physostigmine for toxicity

1. Generic & Trade Names

  • Generic Name: Atropine Sulfate

  • Trade Names: Atropen, Sal-Tropine, Isopto Atropine

2. Class & Mechanism of Action

  • Class: Anticholinergic (muscarinic antagonist)

  • Action:

    • Blocks muscarinic acetylcholine receptors

    • Inhibits parasympathetic nervous system

    • Effects: ↑Heart rate, ↓secretions, pupil dilation

3. Route & Dosage

  • Routes: IV, IM, SC, ET, ophthalmic

  • Dosage:

    • Bradycardia: 0.5-1mg IV (repeat every 3-5 mins)

    • Poisoning: 2-6mg IV (organophosphates)

    • Ophthalmic: 1 drop of 1% solution

4. High Alert Medication?

  • NO - But requires careful monitoring in elderly

5. Indications

  • Symptomatic bradycardia

  • Organophosphate poisoning

  • Pre-operative medication

  • Ophthalmic examinations

6. Contraindications

  • Narrow-angle glaucoma (risk of ↑IOP)

  • Tachycardia (can worsen condition)

  • GI/GU obstruction (↓motility)

  • Myasthenia gravis (weakens muscles)

7. Adverse Reactions & Side Effects

  • Common: Dry mouth, blurred vision, tachycardia

  • Serious:

    • Urinary retention

    • Anticholinergic toxicity (delirium, seizures)

    • Hyperthermia (↓sweating)

8. Nursing Implications

  • Before administration:

    • Check for glaucoma, tachycardia, obstruction

    • Assess baseline vitals, mental status

  • During administration:

    • IV: Give slowly, monitor ECG

    • Ophthalmic: Apply pressure to lacrimal sac

  • Monitoring:

    • Watch for urinary retention, confusion

    • Monitor core temperature in heat

9. Patient Education

  • Avoid driving if vision blurred

  • Report rapid heartbeat or confusion

  • Increase fluids to combat dry mouth

  • Use sunglasses if light sensitivity occurs

10. Special Notes for Nurses

  • Bradycardia: Minimum effective dose 0.5mg IV

  • Poisoning: May require very high doses

  • Elderly: More prone to CNS effects

  • Reversal: Physostigmine for severe toxicity

Note

Atropine is a versatile anticholinergic drug essential for treating bradycardia, poisoning, and pre-operative needs. Nurses must ensure proper dosing, monitor for side effects, and educate patients about potential adverse reactions.